Original Article
Preferential Cephalic Redistribution of Left Ventricular Cardiac Output during Therapeutic Hypothermia for Perinatal Hypoxic-Ischemic Encephalopathy

https://doi.org/10.1016/j.jpeds.2014.01.028Get rights and content

Objective

To determine the relationship between left ventricular cardiac output (LVCO), superior vena cava (SVC) flow, and brain injury during whole-body therapeutic hypothermia.

Study design

Sixteen newborns with moderate or severe hypoxic-ischemic encephalopathy were studied using echocardiography during and immediately after therapeutic hypothermia. Measures were also compared with 12 healthy newborns of similar postnatal age. Newborns undergoing therapeutic hypothermia also had cerebral magnetic resonance imaging as part of routine clinical care on postnatal day 3-4.

Results

LVCO was markedly reduced (mean ± SD 126 ± 38 mL/kg/min) during therapeutic hypothermia, whereas SVC flow was maintained within expected normal values (88 ± 27 mL/kg/min) such that SVC flow represented 70% of the LVCO. The reduction in LVCO during therapeutic hypothermia was mainly accounted by a reduction in heart rate (99 ± 13 vs 123 ± 17 beats/min; P < .001) compared with immediately postwarming in the context of myocardial dysfunction. Neonates with brain injury on magnetic resonance imaging had higher SVC flow prerewarming, compared with newborns without brain injury (P = .013).

Conclusion

Newborns with perinatal hypoxic-ischemic encephalopathy showed a preferential systemic-to-cerebral redistribution of cardiac blood flow during whole-body therapeutic hypothermia, which may reflect a lack of cerebral vascular adaptation in newborns with more severe brain injury.

Section snippets

Methods

Newborns admitted to the Neonatal Intensive Care Unit of the Children's & Women's Health Centre of British Columbia (Canada) and treated with whole-body therapeutic hypothermia for moderate or severe HIE (based on the Sarnat staging system14) were prospectively enrolled between January 2009 and June 2010, following parental informed consent. Newborns were started on therapeutic hypothermia within 6 hours of life according to our institutional standards of presentation with moderate or severe

Results

Newborns treated with therapeutic hypothermia were comparable with the healthy term-born newborns with regard to their birth weight (mean ± SD 3.49 ± 0.52 vs 3.54 ± 0.43 kg; P = .78). The clinical markers of severity of the HIE in newborns are detailed in Table I. Moderate (n = 15) or severe HIE (n = 1) was diagnosed in all 16 newborns, of whom 13 had seizures (diagnosed by combination of clinical signs and cerebral function monitor changes). None of the newborns died before the rewarming was

Discussion

Using echocardiography, we document the hemodynamic changes occurring in the systemic and cerebral circulation in newborns with HIE undergoing whole-body therapeutic hypothermia. For comparison, we performed the same measures in a reference group of healthy term newborns without signs of HIE. Our data indicate a significant reduction in LVCO during therapeutic hypothermia, to almost 60% of values observed in healthy newborns. When comparing measures of systemic (LVCO) and cephalic (SVC) blood

References (29)

  • M. van Handel et al.

    Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review

    Eur J Pediatr

    (2007)
  • F.F. Gonzalez et al.

    Does perinatal asphyxia impair cognitive function without cerebral palsy?

    Arch Dis Child Fetal Neonatal Ed

    (2006)
  • K. Armstrong et al.

    Cardiovascular dysfunction in infants with neonatal encephalopathy

    Arch Dis Child

    (2012)
  • A.D. Edwards et al.

    Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data

    BMJ

    (2010)
  • Cited by (51)

    View all citing articles on Scopus

    P.L. is support by a Clinician-Scientist Award from the Child & Family Research Institute and a Career Investigator Award from the Michael Smith Foundation for Health Research. S.M. is supported by the Bloorview Children's Hospital Chair in Pediatric Neuroscience, with previous support from a Canada Research Chair (Tier 2) and Michael Smith Foundation for Health Research Scholar award. The authors declare no conflicts of interest.

    View full text